U 155 (Alfuzosin hydrochloride extended-release 10 mg)
Pill imprint U 155 has been identified as Alfuzosin hydrochloride extended-release 10 mg.
Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- U 155
- Strength:
- 10 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Unichem Pharmaceuticals (USA), Inc.
More about alfuzosin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 40 Reviews – Add your own review/rating
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Other brands: Uroxatral
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
